BN Business News
会社を追加 →
この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。

ビジネス · 1996/11/11 分で読めます

Notification of Plasma Product Withdrawals and Recalls; Notice of Public Meeting

ローカル自動翻訳 · 情報源の原言語

概要

The Food and Drug Administration (FDA), the National Heart, Lung, and Blood Institute of the National Institutes of Health (NHLBI), and the Centers for Disease Control and Prevention (CDC) are sponsoring a meeting to discuss public notification of withdrawals and recalls of plasma-derived products. The goals of the meeting include: Informing the public about available notification resources; describing the roles and responsibilities of public health service agencies, manufacturers, distributors, and private organizations in the notification process; stimulating discussion about improving the notification system; and soliciting public testimony regarding these issues.

情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →

関連インサイト

ビジネスインサイト →